NCT03851965View on ClinicalTrials.gov

Assessment of the Soluble Urokinase Plasminogen Activator Receptor in Non-cardiac Surgery (SPARSE)

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 15, 2019

Primary Completion Date

November 4, 2020

Study Completion Date

November 5, 2020

Conditions
Surgery--Complications
Interventions
DIAGNOSTIC_TEST

Soluble Urokinase Plasminogen Activator Receptor

Preoperative and postoperative determination of the Soluble Urokinase Plasminogen Activator Receptor levels in patients undergoing non-cardiac major surgery.

Trial Locations (1)

41110

University Hospital of Larisa, Department of Anesthesiology, Larissa

All Listed Sponsors
lead

University of Thessaly

OTHER

NCT03851965 - Assessment of the Soluble Urokinase Plasminogen Activator Receptor in Non-cardiac Surgery (SPARSE) | Biotech Hunter | Biotech Hunter